A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas
多柔比星联合扎利弗利单抗（抗CTLA-4抗体）和巴斯蒂利单抗（抗PD-1抗体）治疗晚期/转移性软组织肉瘤的单臂II期试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0618
Wilky, Breelyn A; Julian, Katherine A; Maleddu, Alessandra; Mailhot, Anne C; Cartwright, Chelsey R; Gao, Dexiang; Moreno Tellez, Cristiam; Kemp, Lindsey E; Therrien, Nicholas R; Chaudhry, Sumra S; Rytlewski, Jeffrey D; Brockman, Qierra R; Davila, Eduardo; Elias, Anthony D
